Page 291 - Medicare Benefit Policy Manual
P. 291
• Peritoneal dialysis (PD), including intermittent PD, continuous ambulatory PD,
and continuous cycling PD, both at home and in-facility;
• All dialysis access options for hemodialysis and peritoneal dialysis; and
• Transplantation.
D. Opportunities for beneficiaries to actively participate in the choice of therapy and
be tailored to meet the needs of the individual beneficiary involved, which
includes, but is not limited to, the following topics:
• Physical symptoms,
• Impact on family and social life,
• Exercise,
• The right to refuse treatment,
• Impact on work and finances,
• The meaning of test results, and
• Psychological impact.
310.5 - Outcomes Assessment
(Rev. 117; Issued: 12-18-09; Effective Date: 01-01-10; Implementation Date: 04-
05-10)
Qualified persons that provide KDE services must develop outcomes assessments that are
designed to measure beneficiary knowledge about CKD and its treatment. The
assessment must be administered to the beneficiary during a KDE session, and be made
available to the Centers for Medicare & Medicaid Services (CMS) upon request. The
outcomes assessments serve to assist KDE educators and CMS in improving subsequent
KDE programs, patient understanding, and assess program effectiveness of:
• Preparing the beneficiary to make informed decisions about their healthcare
options related to CKD, and
• Meeting the communication needs of underserved populations, including persons
with disabilities, persons with limited English proficiency, and persons with
health literacy needs.
320 - Home Infusion Therapy Services
(Rev. 10547, Issued: 12-31-20, Effective: 01-01-21, Implementation: 01-04-21)
Effective January 1, 2021, section 5012 of the 21st Century Cures Act (Pub. L. 114–255),
which added sections 1861(s)(2)(GG) and 1861(iii) of the Act, established a new
Medicare home infusion therapy services benefit. Section 1861(iii) of the Act establishes
certain provisions related to home infusion therapy with respect to the requirements that
must be met for Medicare payment to be made to qualified home infusion therapy